⌘K

Login Start Free

Home/Filings/4/0001354488-16-007554

4//SEC Filing

Opexa Therapeutics, Inc. 4

Accession 0001354488-16-007554

CIK 0001069308operating

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 6:34 PM ET

Size

5.3 KB

Accession

0001354488-16-007554

Insider Transaction Report

Form 4

Period: 2016-05-16

Opexa Therapeutics, Inc.OPXA

President & CEO

Transactions

Award
Employee Stock Option (Right to Buy)
2016-05-16+50,000→ 50,000 total
Exercise: $2.13Exp: 2026-05-16→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]25% vests on the date of grant and the remaining 75% vests quarterly over the ensuing three years.

Documents

1 file

4
issuerdirect_section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Opexa Therapeutics, Inc.

CIK 0001069308

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001069308

Filing Metadata

Form type: 4
Filed: May 17, 8:00 PM ET
Accepted: May 18, 6:34 PM ET
Size: 5.3 KB

View on SEC.gov